LPL Financial’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-20,760
Closed -$3.41K 4629
2022
Q4
$3.41K Sell
20,760
-9,640
-32% -$4.04K ﹤0.01% 4442
2022
Q3
$20K Sell
30,400
-25,000
-45% -$36.8K ﹤0.01% 4330
2022
Q2
$135K Sell
55,400
-5,000
-8% -$13.9K ﹤0.01% 4056
2022
Q1
$244K Sell
60,400
-150
-0.2% -$822 ﹤0.01% 3721
2021
Q4
$485K Buy
+60,550
New +$710K ﹤0.01% 3308

Other funds holding PLXP

LPL Financial's PLXP Position: Q1 2023 in Review

LPL Financial sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2023, closing a stake of 20,760 shares — an estimated $3.41K sold.

LPL Financial first reported a position in PLXP in Q4 2021 and held it in 5 quarters. The position peaked at $485K in Q4 2021. 34 funds tracked by Wall St. Rank hold PLXP as of Q1 2023.

  • LPL Financial reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • LPL Financial sold 20,760 PLx Pharma Inc. Common Stock shares in Q1 2023, an estimated $3.41K.
  • LPL Financial first reported a position in PLx Pharma Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • LPL Financial's PLx Pharma Inc. Common Stock position peaked at $485K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2023.

Based on LPL Financial's 13F filing for Q1 2023, filed 10 May 2023.